Dassault Systèmes and Accelrys Inc. signed a definitive merger agreement for Dassault Systèmes to acquire San Diego-based Accelrys Inc. Under the terms and conditions of the agreement, Dassault Systèmes will make an all cash tender offer for all of the outstanding shares of Accelrys common stock. Dassault intends to acquire any shares of Accelrys not tendered into the tender offer, via a merger that will be effected as soon as possible after the closing of the tender offer.
Combining with Accelrys will enrich the molecular chemistry capabilities from discovery to manufacturing and regulatory requirements of Dassault Systèmes’ formulation-based industry offerings such as life sciences, consumer packaged goods, high tech and energy, as well as advanced manufacturing industries. Accelrys’ list of 2,000 customers includes many of the Fortune 500 companies, with major industry players in pharma/biotech, consumer packaged goods and chemical including Sanofi, Pfizer, GSK, AstraZeneca, DuPont, Shell, BASF, P&G, Unilever and L’Oréal.
“The World demands a new paradigm for sustainability where chemistry, materials and biology meet.This is what the virtual universes enabled by Dassault Systèmes are delivering, capable of harmonizing products, nature and life, from imagination to industry solution experience,” said Bernard Charlès, president and CEO, Dassault Systèmes.“With our passionate and talented teams, Accelrys is convinced that joining Dassault Systèmes will deliver transformational value to our customers by combining science-based innovation with product lifecycle management,” said Max Carnecchia, president and CEO of Accelrys.